Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01260506
Title Single-Arm Open-Label Multicenter Study of VB-111 in Patients With Recurrent Glioblastoma Multiforme
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Vascular Biogenics Ltd. operating as VBL Therapeutics
Indications

glioblastoma

gliosarcoma

Therapies

Bevacizumab + VB-111

Age Groups: adult
Covered Countries USA


No variant requirements are available.